clinical

Videos


Javier Zarranz-Ventura MD, PhD, FEBO, discusses the key highlights from his presentation on a clinical investigation of suitable naïve versus pre-treated DME patients, and what it means for future research.

Comparing suitable naïve versus pre-treated DME patients

Articles

Dr. Jorge Calzada's diabetic macular edema blog dives into his successful treatment of DME with MicroPulse.

Using MicroPulse to reduce injections for DME

Cheryl Guttman is a medical writer based in Deerfield, Ill.

Ophthalmologists face challenges of drug delivery for retinal diseases.

The state of retina therapeutics, dissected by international panel

Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.

Optimizing Care For Patients With Retinal Disorders

The impact of the COVID-19 pandemic on the management of patients with retinal disorders and considerations for how new practices may be adopted into future practice.

Managing Retinal Disorders: Lessons Learned From COVID-19

Dr Mariya Moosajee comments on the next generation of gene therapy for inherited retinal disease and highlights various systems under investigation.

Future Gene Therapy for Inherited Retinal Disease

Visual benefit is not seen during first 2 years of Protocol W study.

Periodic aflibercept injections are studied in NPDR treatment

Considerations for treating retinal disorders with sustained-release drug delivery implants in an effort to address current treatment challenges in the field.

Sustained-Release Drug Delivery for Retinal Disorders

Dexamethasone implant, aflibercept offer a safe treatment option for diabetic macular edema.

Combination therapy lowers treatment burden in DME

In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.

Diabetic Macular Edema